Growth Drivers
Growing Research Activities Associated with Genomics - As per the World Health Organization (WHO), as a result of significant investments made during the COVID-19 pandemic, the percentage of countries capable of carrying out genomic surveillance expanded from 54% to 68% between March 2021 and January 2022.
Increasing Instances of Umbilical Cord Blood Cell Conservation – For instance, in Japan, approximately 36% of childbirth facilities presently provide umbilical cord blood cell storage to private biobanks, which is an increase from 15% in the past.
Escalating Count of Biobanks Globally - For instance, the worldwide number of biobanks reached around 130 by the end of 2018. Hence, the surge in the number of biobanks is expected to enlarge the market size over the forecast period.
Rising Cases of Hemophilia and Bleeding Disorders - Hemophilia is a disorder that interrupts the clotting of blood. It is a rare disorder that can develop in humans based on their genetics. For instance, between 2021 to 2022, approximately 200 thousand people were noticed to be living with hemophilia across the globe.
Challenges
Base Year |
2022 |
Forecast Year |
2023-2033 |
CAGR |
~8% |
Base Year Market Size (2022) |
~ USD 50 Billion |
Forecast Year Market Size (2033) |
~ USD 90 Billion |
Regional Scope |
|
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
8.2% |
Base Year Market Size (2024) |
USD 58.78 billion |
Forecast Year Market Size (2037) |
USD 165.2 billion |
Regional Scope |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?